Garciaz, S., Saillard, C., Hicheri, Y., Hospital, M., & Vey, N. (2021). Venetoclax in Acute Myeloid Leukemia: Molecular Basis, Evidences for Preclinical and Clinical Efficacy and Strategies to Target Resistance. MDPI AG.
Cita Chicago Style (17a ed.)Garciaz, Sylvain, Colombe Saillard, Yosr Hicheri, Marie-Anne Hospital, y Norbert Vey. Venetoclax in Acute Myeloid Leukemia: Molecular Basis, Evidences for Preclinical and Clinical Efficacy and Strategies to Target Resistance. MDPI AG, 2021.
Cita MLA (8a ed.)Garciaz, Sylvain, et al. Venetoclax in Acute Myeloid Leukemia: Molecular Basis, Evidences for Preclinical and Clinical Efficacy and Strategies to Target Resistance. MDPI AG, 2021.
Precaución: Estas citas no son 100% exactas.